Drawing for CROSSODILES

USPTO serial 79293467

CROSSODILES

Reviewed by CopyMark Law Group

Reg. 6324940Status 700Renewal
Filing date
Status date
Registration date
Apr 20, 2021
Examiner
LEASER, ANDREW C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CROSSODILES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical products intended for industry and science, biological preparations intended for industry and science, including polypeptides, heteromultimeric polypeptides, antibodies and antibody derivatives, and light and heavy chains of antibodiesACTIVE
005Pharmaceutical and veterinary preparations based on or containing polypeptides, heteromultimeric polypeptides, antibodies and antibody derivatives, and light and heavy chains of antibodies for the treatment of cardiovascular diseases, diseases of the central nervous system, cancer, thrombosis, respiratory diseases, diabetic disorders, rare diseases including rare blood disorders, infectious diseases, namely, viral and bacterial infections, ocular disorders, metabolic disorders, dermatological disorders, muscular disorders, rheumatic disorders, and immune system disordersACTIVE
042Scientific research and laboratory research services in the field of biotechnology; biotechnical research; consulting in the field of biotechnology, bacteriological research, biological research, research and development of new pharmaceutical products and components for third parties, consulting in the field of clinical trials, namely, providing medical and scientific research information in the field of clinical trials, chemical research and analysis services, medical research, pharmaceutical research servicesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 20, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 17, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 22, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jul 30, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB
Jul 29, 2021FIMPFINAL DISPOSITION PROCESSED
Jul 20, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 20, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 2, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 2, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 30, 2021GPNXNOTIFICATION PROCESSED BY IB
Jan 13, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 13, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 13, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 23, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 23, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 23, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 23, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 23, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 23, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 23, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 23, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 23, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 6, 2020RFNTREFUSAL PROCESSED BY IB
Nov 18, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 18, 2020RFRRREFUSAL PROCESSED BY MPU
Nov 4, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 3, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2020DOCKASSIGNED TO EXAMINER
Sep 15, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Sep 11, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 10, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance